GE HealthCare Technologies Inc. annual ebitda for fiscal TTM was $3.4 billion, a decrease of 10.3% from $3.8 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EBITDA (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| EBITDA | $3.4B | $3.8B | $3.7B | $2.4B | $3.2B | $3.5B | $3.4B | $2.8B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EBITDA (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| EBITDA | $755M | $865M | $902M | $874M | $939M | $1.1B | $931M | $858M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More GEHC metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow · Shares Outstanding
All GEHC financial statements → Interactive GEHC charts →
About TickerBase · Data methodology & sources